BZ WBK Brokerage Home positively assesses perspectives for NEUCA's development in the report concerning the stock listed pharmaceutical distributors. The broker evaluates the securities for PLN 456 what signifies further potential for price growth: 32% YoY. In the previous reports, the brokerage home assessed the price of one share for PLN 422. The BZ WBK analysts recommend the purchase of the shares and call the company their most preferable choice among other companies in that industry.

According to the experts the high values of the NEUCA securities are the result of several factor. Firstly, the market leader's position offers the scale effects. Secondly, the growth of the pharmaceutical wholesale market along with the company's operating costs reduction ensure a higher operating leverage. Thirdly, the development of the Synoptis Pharma and investments in the new, innovative business areas create new possibilities for growths in the long-term perspective.

« Back to list

Neuca SA published this content on 28 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 August 2016 14:00:06 UTC.

Original documenthttp://www.neuca.pl/en/news-single/610/neuca-with-price-pln456-per-share?lastCategory=all

Public permalinkhttp://www.publicnow.com/view/30610B086B59DB45BA9C19D42FCABEA22D7773FE